. 2023 May 2;2023(2):22-0378. doi: 10.1530/EDM-22-0378
This work is licensed under a Table 3.
Localization studies.
| Case number | CT | MRI | OctreoScan | FDG-PET/CT | 68Ga- PET/CT | Pituitary gland MRI | Final diagnosis |
|---|---|---|---|---|---|---|---|
| 1 | 14.4 mm nodule in left lung. Liver metastases. Gastroenterohepatic lymphadenopathy | - | Positive. Hypercaptation in primary tumour | Positive. Hypermetabolism in primary tumour and loco-regional lymphadenopathy | - | No findings | Lung carcinoid |
| 2 | No findings | No findings | Negative | Negative | Positive. Right pulmonary nodule | No findings | Lung carcinoid |
| 3 | - | 7 mm lingular nodule | Positive. Hypercaptation in primary tumour | - | - | Pituitary microadenoma 7 mm size | Lung carcinoid |
| 4 | Nodule in LUL of lung | - | Negative | - | - | Pituitary microadenoma 5 mm size | SCLC |
| 5 | 8 mm nodule in RLL of the lung. | - | Negative | Negative | - | No findings | Lung carcinoid |
| 6 | 85 mm right parahilar mass. Mediastinal lymphadenopathy, pleural, liver and adrenal metastases | - | - | - | - | - | SCLC |
| 7 | Bilateral adrenal hyperplasia. Left adrenal nodule of 14 mm | - | Positive. Hypercaptant left lung area | Positive. Hypermetabolic lesion in the left lung | - | No findings | Unknown origin |
| 8 | 96 mm subcarinal mass infiltrating and compressing surrounding structures (superior vena cava, left atrium, oesophagus, main bronchi, right main pulmonary artery) | No findings at pancreatic-liver level | - | - | - | SCLC | |
| 9 | 17 mm nodule in LUL of the lung | - | Positive. Hypercaptation in primary tumour | - | - | Lung carcinoid | |
| 10 | 20 mm nodule in RUL of the lung | 14 mm cystic lesion in the pancreas compatible with a mucinous tumour | Positive. Hypercaptation in primary tumour | - | Right pituitary microadenoma 5 mm size | Lung carcinoid | |
| 11 | Multifocal and bilateral lung metastases. Liver metastases and peritoneal implants. | - | - | - | - | SCLC | |
| 12 | 44 mm mass in RUL of the lung. | - | - | - | - | - | SCLC |
CT, computed tomography; FDG-PET/CT, fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography; 68Ga- PET/CT,68Ga-DOTATATE positron emission tomography/computed tomography; LUL, left upper lobe; MRI, magnetic resonance imaging; OctreoScan, 111InDTPApentetreotide scintigraphy; RLL, right lower lobe; RUL, right upper lobe; SCLC, small cell lung carcinoma.